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Abstract. Prolonged intake of large amounts of iodine has 
been reported to increase the incidence of hypothyroidism 
in humans, as well as in animals which are prone to spon-
taneously developing autoimmune thyroiditis. We sought 
to investigate the histopathological consequences of large 
amounts of dietary iodine on the thyroid gland and observe 
the occurrence of lymphocytic infiltration associated with 
the time of exposure to iodine. An experimental model using 
non-obese diabetic (NOD) mice was analyzed. A potassium 
iodide intake of 0.2 mg/animal/day was administered via 
drinking water, in experimental groups of 60 and 90 days 
(EG60 and EG90). Distended rough endoplasmic reticulum, 
degenerated mitochondria, debris and amorphous spaces or 
‘ill-defined’ spaces were observed with electron microscopy 
(EM). Lymphocyte infiltration was observed in the two 
groups and the time of exposure to iodine did not increase 
the appearance of lymphocyte infiltration but significantly 
associated with the development of necrosis. The results of the 
present study demonstrated that the NOD mouse is a feasible 
experimental model for thyroiditis induced by iodine adminis-
tration and may represent an opportunity to analyze the steps 
and factors associated with genetic autoimmune thyroiditis. 
High doses of ingested iodine were observed to precdict and 
increase the incidence of the thyroiditis process.
Introduction
The global increase in the prevalence and incidence of thyroid-
itis has been attributed to the introduction of table salt, water 
or oil iodation to prevent goitre in iodine-deficient areas and 
is also associated with the elevated urinary iodine observed 
in non-defficient iodine areas (1-5), which has encouraged the 
development of a number of experimental studies (6,7). Several 
sources of iodine induced thyroiditis were correlated with the 
development of thyroid autoantibodies (8), including iodinated 
radiological contrasts (9-12) and medical drugs (13). However, 
the role of iodine in these processes remains controversial and 
not fully understood.
The initial steps of the autoimmune process in the thyroid 
are poorly understood. Necrosis of follicular cells is considered 
to be the crucial event that triggers the autoimmune process (14) 
and its induction by iodine is well documented (7,15). Thyroid 
epithelial cells are constantly exposed to reactive oxygen 
species (ROS) which are physiologically necessary for thyroid 
hormone synthesis. However, when ROS are produced exces-
sively, they become toxic and induce cellular destruction and 
inflammation in various models of iodine-induced thyroid 
involution (7)
The inflammatory autoimmune condition of the thyroid 
gland depends on numerous factors, presumably including the 
patient genetic profile which is proposed to be responsible for 
at least 50% of all autoimmune thyroiditis, although no conclu-
sive genetic factors have been described (16). Environmental 
factors, such as thiocyanates from tobacco and stress, and 
endogenous, including pregnancy, have been implicated in 
its etiopathogeny (16). There is also evidence to support the 
theory that non-inflammatory processes, such as apoptosis, 
are important in the destruction of thyroid follicles (7,17-20). 
Notably, a significant reduction of caspase-3 expression by 
peripheral T cells in thyroiditis has been demonstrated (21). 
Certain animals spontaneously develop auto-immune thyroid-
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itis (SAT), such as NOD.H-2h4 mice, BB/W rats, Cornell C 
and obese strain chickens (OSCs) (6,22,23), and for this 
reason, the majority have been used in various studies aiming 
to demonstrate the effects of iodine in induced thyroiditis.
The present study aimed to investigate the effects of oral 
iodine consumption in non-obese diabetic (NOD) mice in an 
experimental model tailored to observe the histopathological 
alterations of the thyroid under light microscopy (LM) and 
electron microscopy (EM).
Materials and methods
Animals and treatment. Matrices of wild-type NOD mice were 
acquired from the Center for Development of Experimental 
Models for medicine and Biology (CEDEME) from the 
University of São Paulo (Brazil) and were maintained at the 
Animal Care Facility of Faculty of Medicine of São Paulo 
University (FMUSP). A total of 64 female NOD mice aged 
between 4 and 6 weeks were selected and divided into 4 groups 
of equal size. Of these groups, EG60 and EG90 received 
~0.2 mg/animal/day of oral potassium iodine in drinking 
water while the remaining groups (CG60 and CG90) had no 
oral supplement of iodine. Mice assigned to the first treatment 
group (EG60) were supplemented with iodine for 60 days. 
The second group (EG90) received treatment with iodine 
for 90 days. The control groups were labeled either CG60 
or CG90 depending on whether they were sacrificed after 
60 or 90 days, respectively. The animals were fed ad libitum 
with standard commercial food. All experimental procedures 
were approved by the Ethics Commission for Research Project 
Analysis (CAPPesq) of FMUSP.
Specimen preparation. The animals were weighed and anes-
thetized with intraperitoneal injections of 100 mg/kg ketamine 
and 10 mg/kg xylazine prior to the thyroidectomy. Euthanasia 
was performed by cervical dislocation. The thyroid tissues were 
fixed in buffered formalin (10%) and embedded in paraffin. 
Sections (3 µm) were stained with hematoxylin and eosin 
and the slides were mounted with Entellan medium (Merck, 
Darmstadt, Germany) and analyzed using LM. For EM, the 
sections of thyroid material were fixed in 2% glutaraldehyde 
phosphate buffer 0.1 M (pH 7.4) and dissected while immersed 
in this glutaraldehyde solution at x4 magnification. The first 
post-fixation step was performed in 1% osmium tetroxide and 
the second step with 1% uranila overnight. Material dehydra-
tion was performed using acetone in a graduated series of 
30-100% before being embedded in Araldite resin. Sections 
(70 nm) were examined using a Jeol 1010 transmission elec-
tron mircroscope (TEM) (Tokyo, Japan).
Thyroiditis was defined as mononuclear interstitial infiltra-
tion regardless of its intensity.
Statistical analysis. Pearson's Chi-squared (χ2) test and Fisher's 
exact test (when n<5) were used to study the association 
between iodine treatment and frequency of thyroiditis. P≤0.05 
was considered to indicate a statistically significant difference.
Results
Body weight. The average weight of the animals in the 
experimental and control groups was ~25 g and no evidence of 
catabolic processes was observed in these animals.
Development of thyroiditis. Treatment with oral iodine for 
60 days was associated with the development of thyroiditis in 
NOD mice. Of 16 mice in the EG60 group, 8 exhibited thyroid-
itis with oral iodine ingestion. By contrast, no thyroiditis was 
observed in the CG60 mice (Table I). These differences in the 
frequency of mice with thyroiditis were statistically significant 
(P=0.0012) according to Fisher's exact test. Oral iodine inges-
tion for an additional 30 days did not increase the frequency of 
mice with thyroiditis and 3 animals in the CG90 group exhib-
ited thyroiditis (Table I). The difference in the frequency of 
thyroiditis between the EG90 and CG90 groups, however, was 
not statistically significant (P=0.0812). Of the mice assigned to 
EG90, 1 died of unknown causes.
Light microscopy findings. The most prominent morpho-
logical feature characterizing iodine-induced thyroiditis in 
NOD mice was lymphocyte infiltration which varied from few 
small foci of invading lymphocytes located in the interstitia 
of 3 or 4 follicles (Fig. 1A) to the extensive infiltration of a 
substantial portion of the thyroid lobe (Fig. 1B). The lympho-
cytic infiltration was repeatedly observed in the vicinity of 
large follicles or cysts formed by coalescing follicles (Fig. 2) 
and sometimes coexisted with the necrosis of follicle cells and 
disruption of thyroid architecture (Fig. 3). Atrophic follicles 
with reduced diameters were observed surrounded by or in 
the periphery of a lymphocytic infiltration (Fig. 4). Longer 
treatment with iodine was associated with a more diffuse and 
abundant lymphocyte infiltration pattern (data not shown). 
Similar lymphocyte infiltration was observed in the control 
mice (3 animals in CG90) that exhibited spontaneous thyroid-
itis (data not shown).
Table I. Summary of histological alterations during the time.
Group Exposure period n Thyroiditis Necrosis Relative risk
EG60 60 days 16 8 5 17.00 (1.06-271.78)
EG90 90 days  15a 7 1 2.49 (0.78-7.89)
CG60 60 days 16 0 0 -
CG90 90 days 16 3 0 -
aOne mouse succumbed to unknown causes during study period.
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Focal areas of necrosis were observed in 5 mice of the 
EG60 group and these were observed concomitantly with 
thyroiditis in 3 of these animals. In the EG90 group, 1 mouse 
developed thyroid necrosis without thyroiditis. None of control 
animals in either the CG60 or the CG90 exhibited necrosis 
(Table I).
The follicle cells in iodine-treated mice (EG60) exhib-
ited distended rough endoplasmic reticulum and swollen, 
degenerated mitochondria with a loss of cristae (Fig. 5). 
Other ultrastructural abnormalities included subcellular 
debris (Fig. 6) and clear, ill-defined spaces where no nuclei 
or organelles could be identified with certainty (Fig. 7). We 
Figure 1. Light microscopy showing (A) extensive and (B) focal lymphocytic infiltration. Notice parathyroid gland embedded in the upper portion of section 
that corresponds to thyroid
Figure 2. Light microscopy. Lymphocytic infiltration around coalescent follicles and/or cysts.
Figure 3. Light microscopy. (A) Necrosis and lymphocytic infiltration. (B) Large follicles with rupture of the basal lamina.
Figure 4. Light microscopy. (A) Macrophages inside follicular lumen and and small follicles around infiltration, (B) plasmocitoid cell inside a follicle.
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named this structure an ‘amorphous space’ due to its unknown 
nature. Examination of semi-thin sections of the thyroid 
specimens did not reveal lymphocytic infiltration above the 
regions where ultrastructural alterations were observed (data 
not shown). Accordingly, these ultrastructural abnormalities 
were hypothesised to result from the toxic effects of iodine 
on thyroid tissue, since they were not observed in the control 
animals (Fig. 8).
Discussion
The results presented in the present study partially endorse 
the hypothesis that iodine has an important involvement in 
the development of thyroiditis. This may be observed by the 
comparison of the CG60 group, with no animals affected, 
with the EG60 group, where 50% of the animals exhibited 
thyroiditis. Additionally, a higher frequency of thyroiditis was 
observed in the EG90 group. The etiopathogeny of autoim-
mune thyroiditis continues to be broadly discussed and salt 
iodation and elevated urinary iodine are frequently suggested 
as factors responsible for inducing autoimmune thyroid-
itis (3-5). The results of the present study support this theory 
since the control animals did not develop thyroiditis except at 
the reported incidence of NOD mice (24).
Notably, a longer exposure to iodine did not appear to 
increase the frequency of thyroiditis. This suggests that the 
iodine is a stochastic rather than deterministic factor for the 
development of thyroidal autoimmunity and that iodine may 
trigger an earlier appearance of thyroid autoimmune process. 
We propose that the ultrastructural alterations triggered by 
treatment with iodine represent early signs of follicular cell 
lesions which contribute to exposing the immune system to 
thyroidal autoantigens, thus inducing immune cell infiltration.
The incidence of 18.7% for lymphocytic infiltration in 
the CG90 group is quite similar to that reported by Damotte 
et al (24) (14.3%) using the same mouse lineage. These 
authors also observed that the first lymphocytic infiltration 
in the wild-type NOD mice occurred within 14-15 weeks, but 
predominantly in the male colony.
Similar to the human thyroiditis, the mice also exhibited 
lymphocyte infiltration as the most prominent observation. 
Although we were able to identify some plasma cell-like 
lymphocytes (Fig. 4), in general the infiltrating cells in mouse 
thyroiditis were not predominantly composed of plasma cells, 
as usually can occur in human thyroiditis. The general appear-
ance of the experimental group EG90 appeared to exhibit 
increased severity of lymphocytic infiltration compared with 
EG60, which may be explained, in part, by the evolution of 
inflammatory process.
The frequency of necrosis observed in the EG60 group 
(31.25%), is in agreement with the toxic effect of iodine 
in thyroid cells, as reported by Bagchi et al (23). As antici-
pated, other investigators have described necrosis as the 
first step to antigen exposure in the autoimmune thyroiditis 
process (14,23,25). Of note, the frequency of necrosis 
decreased in the EG90 mice. It is possible that the toxic effects 
of iodine cannot be sustained for a prolonged period of time 
or may evoke a desensitization response following repeated 
exposure. A short-lived toxic effect of iodine may explain why 
necrosis was considerably less frequent following 90 days of 
Figure 5. Electron microscopy. Distended rough endoplasmic reticulum and 
swollen mitochondria.
Figure 8. Electron microscopy. Control group: no alterations observed.
Figure 6. Electron microscopy. Debris and swollen mitochondria.
Figure 7. Electron microscopy. Amorphous spaces.
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treatment. The coexistence of necrosis and thyroiditis possibly 
indicates that necrosis triggers the thyroid autoimmunity as 
suggested by Many et al (14). We propose that acute iodine 
induces blood flow restraint, which contributes to the necrosis 
of follicular cells, resulting in the inflammatory process and 
release of thyroid antigens to immune cells.
EM showed alterations compatible with cell degeneration. 
Distended rough endoplasmatic reticulum and mitochondrial 
lesions with a loss of cristae were described by Nakazawa 
et al (13) in humans following the use of amiodarone for 
19 days. Since no subcellular lesions were observed in the 
control groups (CG60 and CG90), it is possible that the ultra-
structural degeneration is an iodine-induced event.
The amorphous spaces documented in the experimental 
group have not been reported previously. There is no evidence 
concerning the spaces' nature and no reasonable explanation 
for their occurrence may be proposed currently. However, the 
distribution pattern suggests that these spaces are not likely 
to be artefacts. The general appearance of these structures 
mimics the light cells usually detected in normal and patho-
logical tissues, but unlike light cells no nuclei were observed. 
Further studies should be considered to test the reproducibility 
of these findings and their significance. Although unspecific, 
the cellular debris and mitochondrial lesions, even without 
lymphocytic infiltration, appear to be related to iodine and the 
beginning of this autoimmune process.
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